EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

An Automated Single‐Cell Droplet‐Digital Microfluidic Platform for Monoclonal Antibody Discovery

Fatemeh Ahmadi iD, Hao Tran, Natasha Letourneau, Samuel R Little, Annie Fortin, Anna N Moraitis, Steve C C Shih iD

Small · 2024

DOI: 10.1002/smll.202308950 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2024. Verfasst von Fatemeh Ahmadi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electrical and Computer Engineering, Concordia University, 1455 de Maisonneuve Blvd. West, Montréal, Québec, H3G 1M8, Canada. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Microfluidics. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Monoclonal antibody (mAb) discovery plays a prominent role in diagnostic and therapeutic applications. Droplet microfluidics has become a standard technology for high‐throughput screening of antibody‐producing cells due to high droplet single‐cell confinement frequency and rapid analysis and sorting of the cells of interest with their secreted mAbs. In this work, a new method is described for on‐demand co‐encapsulation of cells that eliminates the difficulties associated with washing in between consecutive steps inside the droplets and enables the washing and addition of fresh media. The new platform identifies hybridoma cells that are expressing antibodies of interest using antibody‐characterization assays to find the best‐performing or rare‐cell antibody candidates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalMicrofluidicsAnimalsHybridomasSingle-Cell AnalysisMiceHumansAutomationMicrofluidic Analytical Techniques

Stichwörter der Autor:innen

antibody discoverydeterministic co‐encapsulationdroplet operationsdroplet‐based microfluidics

Substanzen

Antibodies, Monoclonal

Autor:innen und Institutionen

  • Department of Electrical and Computer Engineering, Concordia University, 1455 de Maisonneuve Blvd. West, Montréal, Québec, H3G 1M8, Canada.
  • Centre for Applied Synthetic Biology, Concordia University, 7141 Sherbrooke Street West, Montréal, Québec, H4B 1R6, Canada.
  • Department of Biology, Concordia University, 7141 Sherbrooke Street West, Montréal, Québec, H4B 1R6, Canada.
  • Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, Québec, H4P 2R2, Canada.

ORCID-Profile: Fatemeh Ahmadi, Steve C C Shih

Förderung

  • Natural Sciences and Engineering Research Council of Canada

Zitieren

APA

Ahmadi, F., Tran, H., Letourneau, N., Little, S. R., Fortin, A., Moraitis, A. N., & Shih, S. C. C. (2024). An Automated Single‐Cell Droplet‐Digital Microfluidic Platform for Monoclonal Antibody Discovery. Small. https://doi.org/10.1002/smll.202308950

Vancouver

Ahmadi F, Tran H, Letourneau N, Little SR, Fortin A, Moraitis AN, et al. An Automated Single‐Cell Droplet‐Digital Microfluidic Platform for Monoclonal Antibody Discovery. Small. 2024. doi:10.1002/smll.202308950

BibTeX
@article{Ahmadi2024,
  author = {Ahmadi, Fatemeh and Tran, Hao and Letourneau, Natasha and Little, Samuel R and Fortin, Annie and Moraitis, Anna N and Shih, Steve C C},
  title = {An Automated Single‐Cell Droplet‐Digital Microfluidic Platform for Monoclonal Antibody Discovery},
  journal = {Small},
  year = {2024},
  doi = {10.1002/smll.202308950}
}
Kostenlos starten →